Market closed
ONKURE THERAPEUTICS INC/$OKUR
14:30
15:25
16:15
17:10
18:00
1D1W1MYTD1Y5YMAX
About ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.
Ticker
$OKUR
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
-
Website
OKUR Metrics
BasicAdvanced
$105M
Market cap
-
P/E ratio
-$3.35
EPS
-
Beta
-
Dividend rate
Price and volume
Market cap
$105M
52-week high
$18.23
52-week low
$7.69
Average daily volume
115K
Financial strength
Current ratio
0.649
Quick ratio
0.432
Long term debt to equity
-5.742
Total debt to equity
-124.517
Interest coverage (TTM)
-192.32%
Management effectiveness
Valuation
Price to book
-0.78
Price to tangible book (TTM)
-0.78
Price to free cash flow (TTM)
-3.021
Growth
OKUR News
AllArticlesVideos
OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
GlobeNewsWire·2 weeks ago
OnKure Announces New Date for Upcoming Investor Call
GlobeNewsWire·1 month ago
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for ONKURE THERAPEUTICS INC stock?
ONKURE THERAPEUTICS INC (OKUR) has a market cap of $105M as of December 26, 2024.
What is the P/E ratio for ONKURE THERAPEUTICS INC stock?
The price to earnings (P/E) ratio for ONKURE THERAPEUTICS INC (OKUR) stock is 0 as of December 26, 2024.
Does ONKURE THERAPEUTICS INC stock pay dividends?
No, ONKURE THERAPEUTICS INC (OKUR) stock does not pay dividends to its shareholders as of December 26, 2024.
When is the next ONKURE THERAPEUTICS INC dividend payment date?
ONKURE THERAPEUTICS INC (OKUR) stock does not pay dividends to its shareholders.
What is the beta indicator for ONKURE THERAPEUTICS INC?
ONKURE THERAPEUTICS INC (OKUR) does not currently have a Beta indicator.